Literature DB >> 8658069

Persistent reduction in lung function after Pneumocystis carinii pneumonia in AIDS patients.

S Nelsing1, B N Jensen, V Backer.   

Abstract

By means of serial lung function tests we examined the changes in lung function and possible pulmonary long-term sequelae in AIDS patients with a primary episode of Pneumocystis carinii pneumonia (PCP). A total of 19 patients had lung function tests performed prospectively from the time of PCP diagnosis, at 7 days, 14 days, 1, 2, 3, 4.5, 6 and 9 months after PCP. Forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) were both reduced to a median of 61% of predicted at PCP diagnosis, and were normalized within 1 month and 1 week respectively. The median pulmonary diffusing capacity for carbon monoxide (DLCO) was severely reduced to 43% of predicted during the acute infection. Although DLCO improved significantly during the first 2 months, it remained reduced at a median DLCO of 64% of predicted 9 months after PCP. We conclude that despite a general improvement in lung function during the first 2 months following the PCP diagnosis, ther was a persistent reduction in DLCO up to 9 months following PCP. The pathological mechanisms causing this reduction remain to be established.

Entities:  

Mesh:

Year:  1995        PMID: 8658069     DOI: 10.3109/00365549509032730

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.

Authors:  Ingrid S Lundgren; Janet A Englund; Lauri M Burroughs; Troy R Torgerson; Suzanne Skoda-Smith
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

2.  Association Between CD4+, Viral Load, and Pulmonary Function in HIV.

Authors:  Marjan Islam; Navitha Ramesh; Samuel Kolman; Sanjana Koshy; Matthew Frank; Nadim Salomon; Albert Miller; Mary Harris
Journal:  Lung       Date:  2017-06-24       Impact factor: 2.584

3.  Inflammatory mediators and lung abnormalities in HIV: A systematic review.

Authors:  Breanne M Head; Ruochen Mao; Yoav Keynan; Zulma Vanessa Rueda
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.